PRIMERO SU CORAZON
Live / Applied — First extension granted (statement of use) (as of 23 Jan 2026)
What this means for you
Not registered yet, but its 02 Aug 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98679809
- Mark type
- Design + words
- Filed
- 02 Aug 2024
- Published for opposition
- 08 Jul 2025
- Attorney of record
- Scott J. Major
Goods and services
- Class 035 — Advertising and business services: Promoting public awareness of diabetes and heart disease
Owner
- Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, US
- Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, US
Prosecution history
- 24 Jan 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 23 Jan 2026 — SOU EXTENSION 1 GRANTED
- 23 Jan 2026 — SOU EXTENSION 1 FILED
- 23 Jan 2026 — SOU TEAS EXTENSION RECEIVED
- 02 Sept 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 08 Jul 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 08 Jul 2025 — PUBLISHED FOR OPPOSITION
- 02 Jul 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 05 Jun 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 05 Jun 2025 — EXAMINER'S AMENDMENT ENTERED
- 05 Jun 2025 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 05 Jun 2025 — EXAMINERS AMENDMENT E-MAILED
- 05 Jun 2025 — EXAMINERS AMENDMENT -WRITTEN
- 25 Feb 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 25 Feb 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE